Coverage
-
April 08, 2015
Just weeks before their retrial, Abbott Laboratories urged a California federal judge Wednesday to throw out GlaxoSmithKline's case claiming Abbott violated a license to use one of its HIV drugs, arguing that because GlaxoSmithKline's antitrust claims have been dropped, the case no longer has ties to California.
6 other articles on this case.
View all »